About
I am so fortunate to have had a career that has allowed me to contribute in developing…
Activity
-
Today marks an important milestone for the #RareDisease community. We’re thrilled to announce a successful meeting with the U.S. Food and Drug…
Today marks an important milestone for the #RareDisease community. We’re thrilled to announce a successful meeting with the U.S. Food and Drug…
Liked by Corsee Sanders, Ph.D.
-
I just celebrated a half decade birthday with friends and family , dancing the night away - why only wait for 10 years to go all out … I thought. As…
I just celebrated a half decade birthday with friends and family , dancing the night away - why only wait for 10 years to go all out … I thought. As…
Liked by Corsee Sanders, Ph.D.
-
Our team had a great time at the American Society of Clinical Oncology (ASCO)’s Annual Meeting. Thank you to everyone who stopped by our exhibit and…
Our team had a great time at the American Society of Clinical Oncology (ASCO)’s Annual Meeting. Thank you to everyone who stopped by our exhibit and…
Liked by Corsee Sanders, Ph.D.
Experience & Education
-
Ultragenyx Pharmaceutical Inc.
View Corsee’s full experience
See their title, tenure and more.
or
More activity by Corsee
-
Legend Biotech Obtains Electroporation Technology License from MaxCyte, Inc. Covering Cell-Based Therapies Legend Biotech’s goal is to create a…
Legend Biotech Obtains Electroporation Technology License from MaxCyte, Inc. Covering Cell-Based Therapies Legend Biotech’s goal is to create a…
Liked by Corsee Sanders, Ph.D.
-
OI Research Update: Ultragenyx Orbit and Cosmic Phase 3 Study Enrollment is Complete We are pleased to share exciting news from our partners at…
OI Research Update: Ultragenyx Orbit and Cosmic Phase 3 Study Enrollment is Complete We are pleased to share exciting news from our partners at…
Liked by Corsee Sanders, Ph.D.
-
We are beyond proud to announce that our CEO, Emil Kakkis, has been honored as one of the Most Admired CEOs by the San Francisco Business Times…
We are beyond proud to announce that our CEO, Emil Kakkis, has been honored as one of the Most Admired CEOs by the San Francisco Business Times…
Liked by Corsee Sanders, Ph.D.
-
Thank you to our amazing member leaders who made our two-day, face-to-face meeting last week in Philadelphia unforgettable! All the discussions and…
Thank you to our amazing member leaders who made our two-day, face-to-face meeting last week in Philadelphia unforgettable! All the discussions and…
Liked by Corsee Sanders, Ph.D.
-
Many healthcare leaders know that trustworthy data is critical to improving business performance. But it’s still a challenge to put that data to work…
Many healthcare leaders know that trustworthy data is critical to improving business performance. But it’s still a challenge to put that data to work…
Liked by Corsee Sanders, Ph.D.
-
Members of our Legend team in Belgium recently participated in Kom op tegen Kanker’s cycling challenge benefitting cancer research. Our LEGENDs…
Members of our Legend team in Belgium recently participated in Kom op tegen Kanker’s cycling challenge benefitting cancer research. Our LEGENDs…
Liked by Corsee Sanders, Ph.D.
-
I’ve spent my career focusing on healthcare access around the globe. What a pleasure to have John Oyler join me in a conversation at #ASCO2024 with…
I’ve spent my career focusing on healthcare access around the globe. What a pleasure to have John Oyler join me in a conversation at #ASCO2024 with…
Liked by Corsee Sanders, Ph.D.
-
We are thrilled to receive recognition from NYSE on their historic trading floor. This is a testament to the hard work and dedication of our team, as…
We are thrilled to receive recognition from NYSE on their historic trading floor. This is a testament to the hard work and dedication of our team, as…
Liked by Corsee Sanders, Ph.D.
-
Today, we announced positive top-line results from our Phase 3 study evaluating DTX401, an investigational gene therapy for the treatment of patients…
Today, we announced positive top-line results from our Phase 3 study evaluating DTX401, an investigational gene therapy for the treatment of patients…
Liked by Corsee Sanders, Ph.D.
-
“Generosity is a core value at Ultragenyx, and this is reflected by our team members day in and day out. The Ultragiving employee resource group at…
“Generosity is a core value at Ultragenyx, and this is reflected by our team members day in and day out. The Ultragiving employee resource group at…
Liked by Corsee Sanders, Ph.D.
-
I’m honored to be speaking at #ASPET2024 on what’s next in biotech and what I’m particularly excited about. Hint: AI, the next wave of innovative…
I’m honored to be speaking at #ASPET2024 on what’s next in biotech and what I’m particularly excited about. Hint: AI, the next wave of innovative…
Liked by Corsee Sanders, Ph.D.
-
This #NationalCancerSurvivorDay, we honor the strength and resilience of all cancer survivors. Their determination inspires us daily as we work to…
This #NationalCancerSurvivorDay, we honor the strength and resilience of all cancer survivors. Their determination inspires us daily as we work to…
Liked by Corsee Sanders, Ph.D.
-
It’s easy to follow and yet it’s tough to lead. It makes me particularly appreciate the support from Dr. David Rubin and Dr. Scott Lee who believe in…
It’s easy to follow and yet it’s tough to lead. It makes me particularly appreciate the support from Dr. David Rubin and Dr. Scott Lee who believe in…
Liked by Corsee Sanders, Ph.D.
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More